ACADIA Pharmaceuticals Inc. (LON:0A4W)
London · Delayed Price · Currency is GBP · Price in USD 18.62
-0.02 (-0.11%)
At close: Jan 31, 2025
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of 2.63 billion as of October 20, 2025. Its market cap has increased by 39.09% in one year.
Market Cap
2.63B
Enterprise Value
2.11B
Revenue
743.68M
Ranking
n/a
PE Ratio
16.23
Stock Price
18.62
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from 61.44M to 2.63B, an increase of 4,182.84%. That is a compound annual growth rate of 19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.63B | 7.89% |
| Dec 31, 2024 | 2.44B | -39.57% |
| Dec 29, 2023 | 4.04B | 88.62% |
| Dec 30, 2022 | 2.14B | -22.79% |
| Dec 31, 2021 | 2.77B | -55.49% |
| Dec 31, 2020 | 6.22B | 25.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.74B |
| HSBC Holdings | 165.59B |
| Shell | 155.89B |
| Unilever | 116.14B |
| Rolls-Royce Holdings | 92.83B |
| Rio Tinto Group | 86.80B |
| British American Tobacco p.l.c. | 83.57B |
| GSK plc | 65.34B |